OrbiMed’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,122,770
| Closed | -$30M | – | 126 |
|
|
2023
Q4 | $30M | Hold |
3,122,770
| – | – | 0.6% | 54 |
|
|
2023
Q3 | $8.12M | Hold |
3,122,770
| – | – | 0.17% | 87 |
|
|
2023
Q2 | $14.6M | Hold |
3,122,770
| – | – | 0.26% | 76 |
|
|
2023
Q1 | $11.8M | Sell |
3,122,770
-102,000
| -3% | -$385K | 0.23% | 81 |
|
|
2022
Q4 | $10.2M | Hold |
3,224,770
| – | – | 0.19% | 74 |
|
|
2022
Q3 | $9.71K | Hold |
3,224,770
| – | – | 0.18% | 86 |
|
|
2022
Q2 | $8.03K | Hold |
3,224,770
| – | – | 0.15% | 99 |
|
|
2022
Q1 | $25.1M | Hold |
3,224,770
| – | – | 0.41% | 60 |
|
|
2021
Q4 | $13.4M | Hold |
3,224,770
| – | – | 0.17% | 106 |
|
|
2021
Q3 | $25.5M | Hold |
3,224,770
| – | – | 0.28% | 86 |
|
|
2021
Q2 | $26.1M | Hold |
3,224,770
| – | – | 0.26% | 88 |
|
|
2021
Q1 | $34.6M | Hold |
3,224,770
| – | – | 0.32% | 75 |
|
|
2020
Q4 | $37.9M | Hold |
3,224,770
| – | – | 0.33% | 73 |
|
|
2020
Q3 | $38.8M | Hold |
3,224,770
| – | – | 0.49% | 59 |
|
|
2020
Q2 | $56.3M | Buy |
+3,224,770
| New | +$56.3M | 0.79% | 39 |
|